ANEB: Anebulo Pharmaceuticals, Inc. Stock

by  •  • Comments Off on ANEB: Anebulo Pharmaceuticals, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) n/a
Enterprise Value ($M) n/a
Book Value ($M) 1.90
Book Value / Share n/a
Price / Book n/a
NCAV ($M) 1.39
NCAV / Share n/a
Price / NCAV n/a

Profitability (mra)
Return on Invested Capital (ROIC) -4.17
Return on Assets (ROA) -1.06
Return on Equity (ROE) -1.22

Liquidity (mrq)
Quick Ratio 3.45
Current Ratio 3.45

Balance Sheet (mrq) ($M)
Current Assets 1.96
Assets 2.47
Liabilities 0.57
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -8.31
Net Income -8.20

Cash Flow Statement (mra) ($M)
Cash From Operations -8.09
Cash from Investing 0.00
Cash from Financing -0.06

(click for more detail)
Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-09-25 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K
2024-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-02-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-01-14 809 1,321 61.24
2025-01-13 910 7,613 11.95
2025-01-10 2,562 19,858 12.90

(click for more detail)

Similar Companies
ALTS – JanOne Inc. ALVR – AlloVir, Inc.
ALZN – Alzamend Neuro, Inc. ANIX – Anixa Biosciences, Inc.
APM – Aptorum Group Limited


Financial data and stock pages provided by
Fintel.io